Report provides overview of procedure coding, payment mechanism, reimbursement tariffs and policy considerations for key percutaneous treatment methods, including:
- mechanical and pharmacomechanical (AngioJet, Boston Scientific) thrombectomy,
- catheter-directed and ultrasound-enhanced catheter-directed (EKOS, BTG) thrombolysis.
Analysis is provided for 11 European countries (Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland).
The following clinical situations are considered:
- Stand-alone procedure, performed as primary procedure due to admission due to deep vein thrombosis
- Procedure, performed as secondary procedure for DVT, developed during hospital admission for coronary artery bypass grafting or hip replacement
- Analysis is performed for CABG and hip replacement
- With no complications
- With DVT and no interventional treatment
- With DVT and interventional treatment
- Analysis is performed for CABG and hip replacement
Analysis is performed only for non-elective hospital admission with at least an overnight stay.
Read more and place an order here.
Request sample pages (analysis in the UK) or schedule a call with our manager to receive more information about the report.